Actionable news
All posts from Actionable news
Actionable news in TROV: TrovaGene, Inc.,

Trovagene Appoints Bill Welch as Chief Executive Officer

SAN DIEGO, April 25, 2016 /PRNewswire/ -- Trovagene, Inc. TROV, -16.44% a developer of cell-free molecular diagnostics, today announced the appointment of William (Bill) Welch as Chief Executive Officer, effective immediately. In addition, the Company announced that Matthew Posard, the Company's Chief Commercial Officer, has left the Company.

Chairman of the Board and Interim CEO Thomas Adams said, "We are very excited about having Bill join the Trovagene team. As the Company transitions from a development company to a commercial company, Bill's experience and leadership in commercializing diagnostic products, particularly in the personalized medicine space, will add materially to our ability to accomplish our strategic plan and goals."

Mr. Welch was President and Chief Executive Officer of Sequenom, Inc. from June 2014 to September 2015. Mr. Welch began his career at Sequenom as Senior Vice President, Diagnostics in January 2011 and became President and Chief Operating Officer in June 2014. Prior to joining Sequenom, Mr. Welch was a consultant to molecular diagnostic companies in the personalized medicine sector. From August 2005 to September 2009, Mr. Welch was senior vice president and chief commercial officer at Monogram Biosciences, a bioscience laboratory services company. Prior to his time at Monogram, Mr. Welch was vice president of sales and marketing at La Jolla Pharmaceuticals and vice president of global marketing with Dade Behring MicroScan. Mr. Welch entered the healthcare...